首页 > 市场调查报告书 > 製药

药物开发开发业务受託机关

市场调查报告书

商品编码

1529590

体内 CRO 市场：依分子类型、依治疗领域、按服务类型、按地区

In Vivo CRO Market, By Type of Molecule, By Therapeutic Area, By Service Type, By Geography

出版日期: 2024年07月10日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球体内CRO市场规模为47亿美元，预计2031年将达83.1亿美元，2024年至2031年复合年增长率为8.5%。

报告范围		报告详情
基准年	2023年	2024年市场规模	47亿美元
实际资料	2019-2023	预测期	2024-2031
2024-2031 年预测期复合年增长率	8.50%	2031 年金额预测	83.1亿美元

图：2024 年体内 CRO市场占有率（按地区）

体内 CRO 市场包括受託研究机构(CRO)，这些组织在药物开发的非临床或临床前阶段协助製药和生技公司，并将其研究需求外包给这些专业公司。 CRO 使用活体动物进行实验和测试，以帮助评估候选药物的功效、毒性和安全性。这降低了药物开发商的风险并加快了医药品认证过程。增加药品和医疗创新的研发支出是全球体内 CRO 市场成长的关键驱动力。然而，严格的动物福利法规和对替代检测方法的需求不断增加等因素给市场带来了挑战。

市场动态

全球体内 CRO 市场受到医药品研究开发费用增加、疾病治疗进步以及减少药物开发时间和成本日益增长的需求的推动。然而，对动物测试的严格规定以及对晶片器官和体外测试等替代测试方法的日益偏好正在限制市场。人类晶片技术的开拓为进入该市场的公司提供了一个机会，可以提供新颖的替代测试解决方案，并与行业向非动物测试方法的转变保持一致。 COVID-19 的爆发凸显了 CRO 发现治疗方法并协助药厂进行临床前研究的必要性。

本研究的主要特点

- 本报告详细分析了全球体内 CRO 市场，包括以 2023 年为基准年的预测期（2024-2031）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它还强调了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球体内 CRO 市场的主要企业。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
In Vivo CRO 全球市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于全球体内 CRO 市场分析的各种策略矩阵，将有助于相关人员做出决策。

公司简介
- IQVIA Inc.
- Crown Bioscience
- Taconic Biosciences, Inc.
- PsychoGenics Inc.
- Evotec
- Janvier Labs
- Biocytogen Boston Corp
- GemPharmatech
- Charles River Laboratories
- Icon Plc
- Labcorp Drug Development
- Parexel International Corporation
- SMO Clinical Research（I）Pvt Ltd.
- WuXi AppTec
- ICON plc
- Syneos Health

第10章分析师建议

上升和下降
综合机会图

第十一章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI7148

The global in vivo CRO market is estimated to be valued at USD 4.70 Bn in 2024 and is expected to reach USD 8.31 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 4.70 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	8.50%	2031 Value Projection:	US$ 8.31 Bn

Figure. In Vivo CRO Market Share (%), By Region 2024

In vivo CRO market involves contract research organizations (CROs) that help pharmaceutical and biotechnology companies in non-clinical or pre-clinical stages of drug development by outsourcing their research needs to these specialized firms. CROs conduct experiments and tests on live animals and help evaluate the efficacy, toxicity, and safety of new drug candidates. This reduces risks for drug developers and accelerates the drug approval process. Rising R&D expenditure on pharmaceuticals and medical innovations is a key driver for growth of the global in vivo CRO market. However, factors such as stringent animal welfare regulations and increasing demand for alternative testing methods pose challenges for the market.

Market Dynamics

The global in vivo CRO market is driven by rising pharmaceutical R&D expenditure, advancements in disease treatment, and growing need to reduce drug development timelines and costs. However, stringent regulations for animal testing and rising preference for alternative testing methods, such as organ-on-chip and in vitro testing, act as restraints for the market. Development of human-on-chip technology provides an opportunity for companies in this market to offer novel alternative testing solutions and align with industry shift toward non-animal methods. The COVID-19 outbreak highlighted the need for CROs to find treatments and help drug makers in pre-clinical research, thereby presenting lucrative prospects for players in this market.

Key Features of the Study:

-This report provides in-depth analysis of the global in vivo CRO market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global in vivo CRO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Charles River, Envigo, Taconic Biosciences, Jackson Laboratory, Crown Biosciences, Shanghai SLAC, Changle Rongshi, Pengxin Huasu and Syngene International.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global in vivo CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in vivo CRO market.

Detailed Segmentation-

By Type of Molecule
- Small Molecules
- Large Molecules
By Therapeutic Area
- Oncology
- Cardiology
- Diabetes
- Autoimmune/Inflammation Conditions
- Infectious Diseases
- CNS Conditions
- Others
By Service Type
- Preclinical Testing
- Clinical Research Services
- Laboratory Services
- Consulting Services
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- IQVIA Inc.
- Crown Bioscience
- Taconic Biosciences, Inc.
- PsychoGenics Inc.
- Evotec
- Janvier Labs
- Biocytogen Boston Corp
- GemPharmatech
- Charles River Laboratories
- Icon Plc
- Labcorp Drug Development
- Parexel International Corporation
- SMO Clinical Research (I) Pvt Ltd.
- WuXi AppTec
- ICON plc
- Syneos Health

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type of Molecule
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Service Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global In Vivo CRO Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global In Vivo CRO Market, By Type of Molecule, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Small Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Large Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global In Vivo CRO Market, By Therapeutic Area, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Autoimmune/Inflammation Conditions
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infectious Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
CNS Conditions
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global In Vivo CRO Market, By Service Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Preclinical Testing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinical Research Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Laboratory Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Consulting Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global In Vivo CRO Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Molecule, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Molecule, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Molecule, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Molecule, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Molecule, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Molecule, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- IQVIA Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Crown Bioscience
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Taconic Biosciences, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- PsychoGenics Inc.
- Evotec
- Janvier Labs
- Biocytogen Boston Corp
- GemPharmatech
- Charles River Laboratories
- Icon Plc
- Labcorp Drug Development
- Parexel International Corporation
- SMO Clinical Research (I) Pvt Ltd.
- WuXi AppTec
- ICON plc
- Syneos Health

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

体内 CRO 市场：依分子类型、依治疗领域、按服务类型、按地区